Meeting Banner
Abstract #0482

Gadolinium-Based "Smart" MRI Probes for Enzyme-Targeted Cancer Imaging

MAGNA25Prachi Pandit1, Deju Ye1, John Ronald1, Jianghong Rao1, 2, Brian Rutt1

1Radiology, Stanford University, Stanford, CA, United States; 2Chemistry, Stanford University, Stanford, CA, United States

Recently, significant efforts are being devoted to the development of smart magnetic resonance imaging contrast agents. A common strategy involves a T1 relaxivity change in response to the presence of a target. Our group has devised a novel platform for the development of smart probes based on biocompatible chemical reactions where Gd-containing molecules, under the control of disulfide reduction and/or enzymatic cleavage, get activated to form magnetic nanoparticles and thus provide enhanced relaxivity. We have assessed the MR properties of these smart probes in solution and in cellulo in breast cancer cells.

Keywords

absolute activated activation active agent agents aggregate assay assemble breast cancer carried cell cells cellular chem chemical chemistry clearance cleavage completely compound concentration contrast control decreasing designed determine determined developed devised diagnostic disulfide dual dynamic electron enhanced enzymatic enzyme even excellence field fields forms function generation generations gents greater hours hydrophobic in vivo increasing incubated incubation institute interactions intracellular inversion john least limited live loading marker methylated model molecular molecules nature near overcome pace pelleted percent performance platform predict preliminary prevented prob probe probes produced products program radiology rapid reaction reactions recovery reducing reduction regression relevance respectively safe scattering self sensitivity series slope smart solution spatial specificity square strengths studies successfully synthesized systems targeted tech template thereby though tool transmission trend trig trigger true upon uptake viability widely